Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

The role of histamine degradation gene polymorphisms in moderating the effects of food additives on children's ADHD symptoms.

Stevenson J, Sonuga-Barke E, McCann D, Grimshaw K, Parker KM, Rose-Zerilli MJ, Holloway JW, Warner JO.

Am J Psychiatry. 2010 Sep;167(9):1108-15. doi: 10.1176/appi.ajp.2010.09101529. Epub 2010 Jun 15.

PMID:
20551163
2.

Double dissociation between lab measures of inattention and impulsivity and the dopamine transporter gene (DAT1) and dopamine D4 receptor gene (DRD4).

Gizer IR, Waldman ID.

J Abnorm Psychol. 2012 Nov;121(4):1011-23. doi: 10.1037/a0028225. Epub 2012 May 7.

PMID:
22564179
3.

Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample.

Laucht M, Skowronek MH, Becker K, Schmidt MH, Esser G, Schulze TG, Rietschel M.

Arch Gen Psychiatry. 2007 May;64(5):585-90.

PMID:
17485610
4.

Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder.

Shaw P, Gornick M, Lerch J, Addington A, Seal J, Greenstein D, Sharp W, Evans A, Giedd JN, Castellanos FX, Rapoport JL.

Arch Gen Psychiatry. 2007 Aug;64(8):921-31.

PMID:
17679637
5.

Relations between multi-informant assessments of ADHD symptoms, DAT1, and DRD4.

Gizer IR, Waldman ID, Abramowitz A, Barr CL, Feng Y, Wigg KG, Misener VL, Rowe DC.

J Abnorm Psychol. 2008 Nov;117(4):869-80. doi: 10.1037/a0013297.

PMID:
19025233
6.

Dopamine risk and paternal ADHD symptomatology associated with ADHD symptoms in four and a half-year-old boys.

Auerbach JG, Atzaba-Poria N, Berger A, Landau R, Arbelle S, Raz Y, Ebstein R.

Psychiatr Genet. 2010 Aug;20(4):160-5. doi: 10.1097/YPG.0b013e32833a1f27.

PMID:
20421851
7.

Genetics of preparation and response control in ADHD: the role of DRD4 and DAT1.

Albrecht B, Brandeis D, Uebel-von Sandersleben H, Valko L, Heinrich H, Xu X, Drechsler R, Heise A, Kuntsi J, Müller UC, Asherson P, Steinhausen HC, Rothenberger A, Banaschewski T.

J Child Psychol Psychiatry. 2014 Aug;55(8):914-23. doi: 10.1111/jcpp.12212. Epub 2014 Feb 13.

PMID:
24521003
8.

Evaluation of potential gene-gene interactions for attention deficit hyperactivity disorder in the Han Chinese population.

Qian Q, Wang Y, Li J, Yang L, Wang B, Zhou R, Glatt SJ, Faraone SV.

Am J Med Genet B Neuropsychiatr Genet. 2007 Mar 5;144B(2):200-6.

PMID:
17044099
9.

Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.

Kereszturi E, Tarnok Z, Bognar E, Lakatos K, Farkas L, Gadoros J, Sasvari-Szekely M, Nemoda Z.

Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1431-5. doi: 10.1002/ajmg.b.30704.

PMID:
18214865
10.

Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.

Gabriela ML, John DG, Magdalena BV, Ariadna GS, Francisco de LP, Liz SM, Lino PC, Josefina RG, Ernesto RZ, Carlos CF.

Neurosci Lett. 2009 Feb 27;451(3):257-60. doi: 10.1016/j.neulet.2009.01.004. Epub 2009 Jan 8.

PMID:
19146920
11.

Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.

Kustanovich V, Ishii J, Crawford L, Yang M, McGough JJ, McCracken JT, Smalley SL, Nelson SF.

Mol Psychiatry. 2004 Jul;9(7):711-7.

PMID:
14699430
12.

Dopamine and serotonin transporter genotypes moderate sensitivity to maternal expressed emotion: the case of conduct and emotional problems in attention deficit/hyperactivity disorder.

Sonuga-Barke EJ, Oades RD, Psychogiou L, Chen W, Franke B, Buitelaar J, Banaschewski T, Ebstein RP, Gil M, Anney R, Miranda A, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Thompson M, Asherson P, Faraone SV.

J Child Psychol Psychiatry. 2009 Sep;50(9):1052-63. doi: 10.1111/j.1469-7610.2009.02095.x. Epub 2009 Apr 14.

PMID:
19490304
13.

Dopamine transporter gene polymorphism moderates the effects of severe deprivation on ADHD symptoms: developmental continuities in gene-environment interplay.

Stevens SE, Kumsta R, Kreppner JM, Brookes KJ, Rutter M, Sonuga-Barke EJ.

Am J Med Genet B Neuropsychiatr Genet. 2009 Sep 5;150B(6):753-61. doi: 10.1002/ajmg.b.31010.

PMID:
19655343
14.

Dopaminergic and noradrenergic gene polymorphisms and response to methylphenidate in korean children with attention-deficit/hyperactivity disorder: is there an interaction?

Hong SB, Kim JW, Cho SC, Shin MS, Kim BN, Yoo HJ.

J Child Adolesc Psychopharmacol. 2012 Oct;22(5):343-52. doi: 10.1089/cap.2011.0076.

PMID:
23083021
15.

The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes.

Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, Anney R, Franke B, Gill M, Ebstein R, Buitelaar J, Sham P, Campbell D, Knight J, Andreou P, Altink M, Arnold R, Boer F, Buschgens C, Butler L, Christiansen H, Feldman L, Fleischman K, Fliers E, Howe-Forbes R, Goldfarb A, Heise A, Gabriëls I, Korn-Lubetzki I, Johansson L, Marco R, Medad S, Minderaa R, Mulas F, Müller U, Mulligan A, Rabin K, Rommelse N, Sethna V, Sorohan J, Uebel H, Psychogiou L, Weeks A, Barrett R, Craig I, Banaschewski T, Sonuga-Barke E, Eisenberg J, Kuntsi J, Manor I, McGuffin P, Miranda A, Oades RD, Plomin R, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Taylor E, Thompson M, Faraone SV, Asherson P.

Mol Psychiatry. 2006 Oct;11(10):934-53. Epub 2006 Aug 8. Erratum in: Mol Psychiatry. 2006 Dec;11(12):1139. Aneey, R [corrected to Anney, R].

PMID:
16894395
16.

An association between a dopamine transporter gene (SLC6A3) haplotype and ADHD symptom measures in nonclinical adults.

Tong JH, Cummins TD, Johnson BP, McKinley LA, Pickering HE, Fanning P, Stefanac NR, Newman DP, Hawi Z, Bellgrove MA.

Am J Med Genet B Neuropsychiatr Genet. 2015 Mar;168B(2):89-96. doi: 10.1002/ajmg.b.32283. Epub 2015 Feb 5.

PMID:
25656223
17.

Association between the dopamine transporter gene and the inattentive subtype of attention deficit hyperactivity disorder in Taiwan.

Shang CY, Gau SS, Liu CM, Hwu HG.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):421-8. doi: 10.1016/j.pnpbp.2010.08.016. Epub 2010 Aug 26.

PMID:
20800641
18.

The interactions among organophosphate pesticide exposure, oxidative stress, and genetic polymorphisms of dopamine receptor D4 increase the risk of attention deficit/hyperactivity disorder in children.

Chang CH, Yu CJ, Du JC, Chiou HC, Chen HC, Yang W, Chung MY, Chen YS, Hwang B, Mao IF, Chen ML.

Environ Res. 2018 Jan;160:339-346. doi: 10.1016/j.envres.2017.10.011. Epub 2017 Oct 17.

PMID:
29054088
19.

Increased risk of attention-deficit/hyperactivity disorder associated with exposure to organophosphate pesticide in Taiwanese children.

Yu CJ, Du JC, Chiou HC, Chung MY, Yang W, Chen YS, Fuh MR, Chien LC, Hwang B, Chen ML.

Andrology. 2016 Jul;4(4):695-705. doi: 10.1111/andr.12183. Epub 2016 Apr 12.

20.

Family-based association study of DAT1 and DRD4 polymorphism in Korean children with ADHD.

Kim YS, Leventhal BL, Kim SJ, Kim BN, Cheon KA, Yoo HJ, Kim SJ, Badner J, Cook EH.

Neurosci Lett. 2005 Dec 30;390(3):176-81. Epub 2005 Sep 13.

PMID:
16165273

Supplemental Content

Support Center